CREATIVE REALITIES INC (CREX) Fundamental Analysis & Valuation

NASDAQ:CREX • US22530J3095

Current stock price

3.83 USD
-0.09 (-2.3%)
Last:

This CREX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CREX Profitability Analysis

1.1 Basic Checks

  • CREX had positive earnings in the past year.
  • In the past year CREX has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
  • In multiple years CREX reported negative operating cash flow during the last 5 years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

1.2 Ratios

  • CREX has a Return On Assets (-5.63%) which is in line with its industry peers.
  • CREX has a Return On Equity of -17.30%. This is comparable to the rest of the industry: CREX outperforms 48.89% of its industry peers.
Industry RankSector Rank
ROA -5.63%
ROE -17.3%
ROIC N/A
ROA(3y)-5.05%
ROA(5y)-2.26%
ROE(3y)-13.75%
ROE(5y)-6.26%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • With a Gross Margin value of 44.93%, CREX perfoms like the industry average, outperforming 54.44% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CREX has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for CREX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y-0.69%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CREX Health Analysis

2.1 Basic Checks

  • CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CREX has more shares outstanding than it did 1 year ago.
  • CREX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CREX is higher compared to a year ago.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 0.20, we must say that CREX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.20, CREX is doing worse than 66.67% of the companies in the same industry.
  • CREX has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
  • CREX has a Debt to Equity ratio of 1.17. This is comparable to the rest of the industry: CREX outperforms 41.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 0.2
ROIC/WACCN/A
WACC8.17%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 0.85 indicates that CREX may have some problems paying its short term obligations.
  • CREX has a Current ratio of 0.85. This is in the lower half of the industry: CREX underperforms 67.78% of its industry peers.
  • CREX has a Quick Ratio of 0.85. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.67, CREX is not doing good in the industry: 76.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.67
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CREX Growth Analysis

3.1 Past

  • CREX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 160.61%, which is quite impressive.
  • The Revenue has grown by 12.54% in the past year. This is quite good.
  • CREX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.80% yearly.
EPS 1Y (TTM)160.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)12.54%
Revenue growth 3Y9.7%
Revenue growth 5Y26.8%
Sales Q2Q%117.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • CREX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.22% yearly.
EPS Next Y30.05%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year83.66%
Revenue Next 2Y45.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

4

4. CREX Valuation Analysis

4.1 Price/Earnings Ratio

  • CREX is valuated rather expensively with a Price/Earnings ratio of 19.15.
  • CREX's Price/Earnings ratio is a bit cheaper when compared to the industry. CREX is cheaper than 72.22% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, CREX is valued a bit cheaper.
  • CREX is valuated correctly with a Price/Forward Earnings ratio of 14.73.
  • Based on the Price/Forward Earnings ratio, CREX is valued a bit cheaper than the industry average as 63.33% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, CREX is valued a bit cheaper.
Industry RankSector Rank
PE 19.15
Fwd PE 14.73
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CREX is valued a bit more expensive than 62.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.8
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CREX Dividend Analysis

5.1 Amount

  • CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CREX Fundamentals: All Metrics, Ratios and Statistics

CREATIVE REALITIES INC

NASDAQ:CREX (4/24/2026, 7:27:55 PM)

3.83

-0.09 (-2.3%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-14
Earnings (Next)05-12
Inst Owners10.26%
Inst Owner Change46.39%
Ins Owners5.61%
Ins Owner Change0%
Market Cap90.00M
Revenue(TTM)57.23M
Net Income(TTM)-8.51M
Analysts84
Price Target8.29 (116.45%)
Short Float %0.48%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-138.26%
Min EPS beat(2)-194.12%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)43.74%
Min EPS beat(4)-194.12%
Max EPS beat(4)601.45%
EPS beat(8)4
Avg EPS beat(8)38.04%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)5.34%
Revenue beat(4)2
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)5
Avg Revenue beat(8)-0.1%
Revenue beat(12)5
Avg Revenue beat(12)-3.3%
Revenue beat(16)5
Avg Revenue beat(16)-3.02%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.15
Fwd PE 14.73
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 1.83
P/tB N/A
EV/EBITDA 46.8
EPS(TTM)0.2
EY5.22%
EPS(NY)0.26
Fwd EY6.79%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS2.44
BVpS2.09
TBVpS-1.7
PEG (NY)0.64
PEG (5Y)N/A
Graham Number3.06897 (-19.87%)
Profitability
Industry RankSector Rank
ROA -5.63%
ROE -17.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.93%
FCFM N/A
ROA(3y)-5.05%
ROA(5y)-2.26%
ROE(3y)-13.75%
ROE(5y)-6.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y-0.69%
F-Score2
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA 17.19
Cap/Depr 38.42%
Cap/Sales 4.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.67
Altman-Z 0.2
F-Score2
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)77.38%
Cap/Depr(5y)93.8%
Cap/Sales(3y)6.26%
Cap/Sales(5y)6.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y30.05%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.54%
Revenue growth 3Y9.7%
Revenue growth 5Y26.8%
Sales Q2Q%117.23%
Revenue Next Year83.66%
Revenue Next 2Y45.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-436.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year278.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1866.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-329.22%
OCF growth 3YN/A
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


Can you provide the valuation status for CREATIVE REALITIES INC?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


How profitable is CREATIVE REALITIES INC (CREX) stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to grow by 30.05% in the next year.